1011.HK Sygnały na żywo | Maksymalizuj zyski z Getagraph.com

Live Chart Being Loaded With Signals

Commentary (2 geg. 2024 @ 09:30):

Stats
Dzisiejszy wolumen	852 000
Średni wolumen	7.75M
Kapitalizacja rynkowa	76.59M
EPS	HKD0 ( 2023-08-31 )
Last Dividend	HKD0.0350 ( 2018-07-10 )
Next Dividend	HKD0 ( N/A )
P/E	-1.450
ATR14	HKD0.00100 (3.45%)

China NT Pharma Group Korelacja

10 Najbardziej pozytywne korelacje

10 Najbardziej negatywne korelacje

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

China NT Pharma Group Finanse

Annual	2023
Przychody:	HKD7.37M
Zysk brutto:	HKD7.37M (100.00 %)
EPS:	HKD-0.0169

FY	2023
Przychody:	HKD7.37M
Zysk brutto:	HKD7.37M (100.00 %)
EPS:	HKD-0.0169

FY	2022
Przychody:	HKD207.09M
Zysk brutto:	HKD125.29M (60.50 %)
EPS:	HKD-0.0350

FY	2021
Przychody:	HKD226.70M
Zysk brutto:	HKD145.46M (64.16 %)
EPS:	HKD-0.0792

Financial Reports:

No articles found.

China NT Pharma Group Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)

China NT Pharma Group Dividend Information - Ex Dividend Junior

Dividend Sustainability Score: 2.59 - low (50.00%) | Divividend Growth Potential Score: 2.40 - No dividend growth expected in the near future

Information

First Dividend	HKD0.0100	2016-05-31
Last Dividend	HKD0.0350	2018-07-10
Next Dividend	HKD0	N/A
Payout Date	2018-08-02
Next Payout Date	N/A
# dividends	3	--
Total Paid Out	HKD0.0700	--
Avg. Dividend % Per Year	0.00%	--
Score	1.28	--
Div. Sustainability Score	2.59
Div.Growth Potential Score	2.40
Div. Directional Score	2.50	--

Next Divdend (Est)
(2025-01-27)

HKD0 Estimate 0.00 %

Dividend Stability

0.02 Very Bad

Dividend Score

1.28

Pay Frequency

Annually

Yearly Payout

Year	Amount	Yield

Dividend Commentary

The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Top 10 dividend Companies for HKSE

Symbol	Title	Last dividend	Frequency	Yearly Dividend
2628.HK	Ex Dividend Junior	2023-07-05	Annually	0.00%
1408.HK	Ex Dividend Junior	2023-05-30	Annually	0.00%
0489.HK	No Dividend Player	2023-06-23	Annually	0.00%
6837.HK	No Dividend Player	2023-06-30	Annually	0.00%
1958.HK	Ex Dividend Junior	2023-06-28	Annually	0.00%
0991.HK	Ex Dividend Junior	2023-06-30	Sporadic	0.00%
0101.HK	Ex Dividend Junior	2023-09-12	Semi-Annually	0.00%
3328.HK	Ex Dividend Knight	2023-07-04	Annually	0.00%
1568.HK	Ex Dividend Junior	2023-06-05	Annually	0.00%
0596.HK	Ex Dividend Junior	2023-06-30	Annually	0.00%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	-0.259	1.500	-5.17	-7.76	[0 - 0.5]
returnOnAssetsTTM	-0.133	1.200	-4.43	-5.32	[0 - 0.3]
returnOnEquityTTM	0.149	1.500	9.45	10.00	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	0.0185	0.800	-4.91	-3.93	[1 - 3]
quickRatioTTM	0.0174	0.800	-4.60	-3.68	[0.8 - 2.5]
cashRatioTTM	0.00229	1.500	-1.098	-1.648	[0.2 - 2]
debtRatioTTM	1.046	-1.500	10.00	-10.00	[0 - 0.6]
interestCoverageTTM	0	1.000	-1.111	-1.111	[3 - 30]
operatingCashFlowPerShareTTM	0.00526	2.00	10.00	10.00	[0 - 30]
freeCashFlowPerShareTTM	0.00439	2.00	10.00	10.00	[0 - 20]
debtEquityRatioTTM	-1.014	-1.500	-4.06	6.08	[0 - 2.5]
grossProfitMarginTTM	0.607	1.000	3.22	3.22	[0.2 - 0.8]
operatingProfitMarginTTM	0.215	1.000	7.70	7.70	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0.0343	1.000	-0.921	-0.921	[0.2 - 2]
assetTurnoverTTM	0.514	0.800	9.91	7.92	[0.5 - 2]
Total Score				2.59

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	-1.342	1.000	-0.237	0	[1 - 100]
returnOnEquityTTM	0.149	2.50	9.65	10.00	[0.1 - 1.5]
freeCashFlowPerShareTTM	0.00439	2.00	10.00	10.00	[0 - 30]
dividendYielPercentageTTM	0	1.500	0	0	[0 - 0.4]
operatingCashFlowPerShareTTM	0.00526	2.00	10.00	10.00	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	0.00227	1.500	-3.32	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.0697	1.000	-0.757	0	[0.1 - 0.5]
Total Score				2.40

China NT Pharma Group

China NT Pharma Group Company Limited, together with its subsidiaries, engages in the research and development, manufacturing, sales, and distribution of pharmaceutical products in the People's Republic of China and internationally. It manufactures, sells, and trades in prescription medicines for the tumor and blood system diseases, digestive system diseases, central nervous system diseases, diseases of respiratory system, and other therapeutic fields; and produces and sells NT branded products and generic drugs. The company also provides marketing and promotion services to suppliers, and logistics and consulting services. China NT Pharma Group Company Limited was founded in 1995 and is headquartered in Suzhou, the People's Republic of China.